Trending News

#Covid variants #Covid-19 #Public health

PerkinElmer launches kit to strengthen SARS-CoV-2 surveillance 

PerkinElmer has announced the research use only (RUO) launch of the NEXTFLEX Variant-Seq SARS-CoV-2 Kit v2 to accelerate the detection of SARS-CoV-2 variants, which will allow laboratories to increase sequencing throughput and make reliable variant identifications.  What is NEXTFLEX?   Using positive SARS-CoV-2 samples, the NEXTFLEX… Read More

#Covid-19 #News #Trending News

#Contraception #Healthcare #Public health

The first transdermal contraceptive patch licensed in the UK  

Gedeon Richter has become marketing authorisation holder for Evra, a once-weekly contraception for women of fertile age, which they say is the first and only transdermal contraceptive patch licenced in the UK.   Tamas Neubauer, Managing Director of UK and Ireland at Gedeon Richter, believes that the addition of a patch to their… Read More

#News #Trending News

#Biotechnology #CAR-T #Flow Cytometry #Tumour #Webinar

Webinar: Imaging for target discovery for CAR T cell therapy

In this free webinar, Dr. Christoph Herbel presents a newly developed workflow which combines flow cytometry–based screenings with high-parameter imaging to identify and validate new tumour markers in an unbiased approach.   The event, Kill the tumour, spare the healthy tissue. Ultra high-content imaging enables target discovery for CAR T cell therapy, was hosted by DDW and supported by Miltenyi Biotec.  It… Read More

#News #Trending News

#Covid-19 #Immunology / Virology & Vaccines #Plant-based

First plant-based Covid-19 vaccine promising says Medicago and GSK

Results from the Phase III placebo-controlled efficacy study of Medicago’s plant-based Covid-19 vaccine candidate in combination with GlaxoSmithKline’s pandemic adjuvant have shown positive results. Vaccine efficacy was demonstrated in an environment dominated by SARS-CoV-2 variants, unlike most published Phase III efficacy trials for currently licensed Covid-19 vaccines that were conducted… Read More

#Editor's Choice #News #Trending News

#Covid-19 #Drug development #Drug discovery #Immunology / Virology & Vaccines #Omicron #Therapeutics

Breakthrough: New drug for Omicron and coronavirus strains 

Infex Therapeutics scientists have announced a breakthrough in laboratory trials of a new drug to treat Covid-19 and new variants of the disease, such as the Omicron variant.   Infex’s COV-X programme inhibits a new protease target that is responsible for viral replication across the broad spectrum of SARS-CoV-1, MERS-CoV and SARS-CoV-2. As such,… Read More

#Covid-19 #News #Trending News

#Biotechnology #Covid-19 #Drug discovery #Immunology / Virology & Vaccines

Covid-19 treatment cuts hospitalisation and death by 79% 

The Medicines and Healthcare products Regulatory Agency (MHRA), in the UK, has approved GSK and Vir Biotechnology’s Covid-19 drug Xevudy (sotrovimab), after it was found to be safe and effective at reducing the risk of hospitalisation and death in people with mild to moderate Covid-19 infection who are at an increased risk of developing severe… Read More

#Covid-19 #News #Trending News

#Cancer research #Clinical trials #Drug therapy #Therapeutics

Phase I clinical study begins for patients with advanced liver cancer 

The National University Cancer Institute, Singapore (NCIS) and MiNA Therapeutics have dosed the first patients in an investigator-sponsored Phase I study of MiNA’s small activating RNA oligonucleotide, MTL-CEBPA, in combination with first-line standard of care, atezolizumab and bevacizumab, in patients with previously untreated, advanced hepatocellular carcinoma (HCC). Atezolizumab and bevacizumab are… Read More

#Cancer Research #News #Trending News

#Clinical trials #Drug development

Data suggests racial diversity underrepresented in clinical trials 

Phesi has analysed protocol design data and showed that Asian, Hispanic and Latino, Native Americans and Alaska natives, Native Hawaiians and other Pacific Islander patient subpopulations were all significantly and consistently underrepresented over the decade. Black and African American patients appear to have become better represented over the past decade.  The study  The data was… Read More

#News #Trending News #Trends & Analysis

#CAR-T #Cell therapy #Drug screening #Drug targets #Flow Cytometry #Tumour

How to assess the safety profile of potential CAR targets 

CAR T cell technology provides the foundation for established immunotherapies against certain types of blood cancer and holds great promise for the fight against many solid tumours too. One major drawback of conventional CAR T cell technology, which relies on a single target antigen, is the lack of tumour-associated antigens (TAAs) that… Read More

#News #Trending News

#Biopharmaceuticals #Heart disease

Sweet talk: “sugar soap” reverses blocked arteries 

Australian biopharmaceutical company Cholrem have produced CAVADEX (Beta-Cyclodextrin), a product which removes cholesterol from damaged and narrowed arteries after a few months of treatment, leading to increased blood flow.  Context Atherosclerosis, also known as heart disease, is reportedly the western world’s number one killer of people. This disease results… Read More

#News #Trending News

#Clinical trials #Neurology #Rare disease

First patient enrollment for ALS treatment trial 

Ferrer, a pharmaceutical company focused on neurological disorders and pulmonary vascular and interstitial lung diseases, has enrolled the first patient in its Amyotrophic Lateral Sclerosis (ALS) Deceleration with ORal Edaravone (ADORE), FNP122 Phase III clinical trial.   The trial   The trial will enrol about 300 patients across European countries and it will evaluate… Read More

#News #Trending News

#Covid-19 #Immunology / Virology & Vaccines #Moderna #mRNA

Moderna announces strategy to address Omicron SARS-CoV-2 variant 

Moderna has announced updates to its strategy to address SARS-CoV-2 variants of concern, given the emergence of the B.1.1.529 (Omicron) variant.   What is Omicron?  The recently described Omicron variant includes mutations seen in the Delta variant that are believed to increase transmissibility and mutations seen… Read More

#Covid-19 #News #Trending News